| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1526-4610.43.7S.5.X |
| P698 | PubMed publication ID | 12887391 |
| P50 | author | David W Dodick | Q78768282 |
| P2860 | cites work | The global burden of disease study: implications for neurology | Q28138436 |
| Botulinum toxin A for axillary hyperhidrosis (excessive sweating). | Q31921364 | ||
| Prevalence and burden of migraine in the United States: data from the American Migraine Study II. | Q31974113 | ||
| Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study | Q33927756 | ||
| Migraine--current understanding and treatment | Q34504002 | ||
| Migraine: preventive treatment | Q34852689 | ||
| Double-blind study of botulinum toxin in spasmodic torticollis | Q39542317 | ||
| Prevalence of frequent headache in a population sample | Q46159664 | ||
| Burden of migraine in the United States: disability and economic costs. | Q50644584 | ||
| An association between migraine and cutaneous allodynia. | Q51402389 | ||
| P921 | main subject | headache | Q86 |
| migraine | Q133823 | ||
| primary headache disorder | Q54927701 | ||
| headache disorder | Q67841409 | ||
| P304 | page(s) | S25-33 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside | |
| P478 | volume | 43 Suppl 1 |
| Q44772857 | 24-hour distribution of migraine attacks. |
| Q35745530 | A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation |
| Q34003508 | A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches |
| Q33720660 | Botulinum as a Toxin for Treating Post-herpetic Neuralgia |
| Q28194984 | Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations |
| Q37955981 | Botulinum toxin and the treatment of headache: a clinical review |
| Q51799894 | Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. |
| Q46398990 | Botulinum toxin-induced resolution of axillary granular parakeratosis |
| Q47972233 | CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study. |
| Q37630537 | CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine |
| Q39132962 | Clinically significant placebo analgesic response in a pilot trial of botulinum B in patients with hand pain and carpal tunnel syndrome |
| Q48608495 | Does single-file botox injection really work for primary headache? |
| Q64086211 | Entrapment Neuropathy: A Concept for Pathogenesis and Treatment of Headaches-A Narrative Review |
| Q45944411 | Evaluation of botulinum toxin A in treatment of tinnitus. |
| Q36600278 | Investigating prophylactic botulinum toxin type A for chronic headache disorders |
| Q83025445 | Is botulinum toxin useful in treating headache? No |
| Q36947170 | Is there hope for chronic pain and headache? |
| Q36099528 | Management of chronic daily headache: challenges in clinical practice |
| Q37418971 | Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache. |
| Q39342164 | Treatment of chronic refractory intractable headache with botulinum toxin type a: a retrospective study |
Search more.